Paper Details

  1. Home
  2. Paper Details

The role of omadacycline in skin and soft tissue infections.

Author: MontraversPhilippe, TanakaSebastien, Tran-DinhAlexy

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review summarizes the development of omadacycline, a new aminomethylcycline antibiotic with potential benefits for treating skin and soft tissue infections (SSTIs). Omadacycline exhibits activity against methicillin-resistant Staphylococcus aureus (MRSA) and other drug-resistant pathogens, making it a promising candidate for addressing unmet medical needs in SSTI treatment.
Paper Details　
Original Abstract of the Article :
Skin and soft tissue infections (SSTIs) are among the most frequent infections, contributing to significant morbidity and healthcare costs. Although numerous antibiotics are available for this indication, several medical needs remain unmet, especially for treating methicillin-resistant Staphylococcu...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1097/QCO.0000000000000429

データ提供：米国国立医学図書館（NLM）

Omadacycline: A New Hope for Treating Skin and Soft Tissue Infections

This research explores the potential of omadacycline, a new aminomethylcycline antibiotic, for treating skin and soft tissue infections (SSTIs). It's like discovering a new desert herb with potent antibacterial properties, offering a new solution for a common problem.

Omadacycline: A Potential Weapon Against Resistant Infections

The study highlights the potential of omadacycline to treat methicillin-resistant Staphylococcus aureus (MRSA) infections, a growing challenge in the fight against bacterial infections. It's like finding a new weapon in the desert explorer's arsenal, effective against a particularly formidable foe.

Navigating the Desert of Bacterial Infections: A New Approach

This research offers a promising new approach to treating SSTIs, particularly those caused by drug-resistant bacteria. It's like finding a new path through a treacherous desert, offering a safer and more effective route.

Dr.Camel's Conclusion

Omadacycline shows promise as a new treatment option for SSTIs, offering hope for patients battling resistant infections. It's like a desert oasis offering a fresh and potent source of relief. Further research is needed to confirm its effectiveness and safety, but omadacycline represents a potential new weapon in the fight against bacterial infections.

Date :
  1. Date Completed 2019-07-18
  2. Date Revised 2019-07-18
Further Info :

Pubmed ID

29251672

DOI: Digital Object Identifier

10.1097/QCO.0000000000000429

Related Literature

Article Analysis
・Side Effects of omadacycline
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.